In certain subtypes of AML, the down-regulation of ELF4 expression possibly promotes AML pathogenesis and resistance to chemotherapy by altering the growth properties of leukemic stem cells, similar to what is observed in ELF4-deficient HSCs. The gene discussed is ELF4; the disease is acute myeloid leukemia.